Thus, NLRC5 likely remains an important component of HLA-I gene transcription, and the difficulty to detect changes in its expression during T1D pathogenesis possibly reflect sufficient reserves of the protein to respond to changes elsewhere in the pathway [e.g. STAT1 (21)]. The gene discussed is NLRC5; the disease is type 1 diabetes mellitus.